PATENT CLAIM ANALYSIS

Application Number: 16111929
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-05
Patent Classification: ["424", "258100"]

Abstract:
The use of flagellin and flagellin related polypeptide for the protection of mammals from the effects of apoptosis is described.

Claim (Index 14):
A method of treating apoptosis-mediated tissue damage in a patient in need thereof comprising administering to said patient a composition comprising a pharmaceutically effective amount of a flagellin polypeptide, wherein the polypeptide comprises an amino acid sequence selected from SEQ ID Nos: 8, 10, 12, 30, 32, 34, 36, 38, 40, 42, and 44, and wherein the apoptosis is attributable to radiation.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 96.0
- Lexical Diversity: 1.23529
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13110720', '15254695', '14559669', '14828111', '15794804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7916427936590146
- 35 USC 102 Novelty (BERT): 0.629536180510679
- Combined Prediction Score: 0.7754321323441811
- Mean Citation Score: 569.5859820000003
- Max Citation Score: 571.27356
- Similarity Product: 556.1180654129789

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test